Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery (TRIGS-D)
NCT05470816Phase 3Active, not recruiting
- Start
- Nov 2022
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in postoperative delirium (POD) comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Incidence of delirium in the first 3 days postoperatively. Started Nov 2022; status: active, not recruiting.
02
Drugs
tranexamic acid
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05470816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05470816.